---
title: "Weekly Recap | Veeva Systems -CL -0.72%, consensus target above spot"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305539020.md"
description: "VEEV.US closed the week at $301.53, down 0.72%. The S&P 500 rose 2.51% over the same window, leaving the stock about 3.23 percentage points behind the benchmark. Day by day, Monday (Nov 9) through Wednesday (Nov 11) saw an early push higher, with the intraweek peak of $311.38 hit on Wednesday before a pullback. Thursday (Nov 12) marked the week’s low at $296.80, and Friday (Nov 13) saw a modest stabilisation. The overall pattern was a failed rally, with a weekly amplitude of 4.8%."
datetime: "2026-11-14T07:16:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305539020.md)
  - [en](https://longbridge.com/en/news/305539020.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305539020.md)
generator: "portal-rs"
---

# Weekly Recap | Veeva Systems -CL -0.72%, consensus target above spot

## The Week

VEEV.US closed the week at $301.53, down 0.72%. The S&P 500 rose 2.51% over the same window, leaving the stock about 3.23 percentage points behind the benchmark. Day by day, Monday (Nov 9) through Wednesday (Nov 11) saw an early push higher, with the intraweek peak of $311.38 hit on Wednesday before a pullback. Thursday (Nov 12) marked the week’s low at $296.80, and Friday (Nov 13) saw a modest stabilisation. The overall pattern was a failed rally, with a weekly amplitude of 4.8%.

## Key Events

The standout company development was UCB’s adoption of Vault CRM. On Monday (Nov 9), commentary began circulating on how investors might respond, and by Thursday (Nov 12) the focus had shifted to whether the stock still looks cheap after the win. During the same week, Veeva also said shared data platforms could accelerate global drug approvals, reinforcing its life-sciences cloud narrative. On Friday (Nov 13), the company set the date for its fiscal 2027 third-quarter results call, leaving a clear verification window for the week ahead.

## Analyst Ratings

Coverage totalled 30 firms this week: 13 rate the stock buy, 7 overweight, 8 hold, 1 sell, and 1 no opinion, with none rating underweight. The consensus recommendation is buy, and the consensus target of $326.41 sits 8.25% above the spot price of $301.53. The target range runs from $180 to $400, reflecting wide disagreement. Within the healthcare information services industry, VEEV.US ranks #1 in ratings out of 34 covered names.

## The Week Ahead

On the earnings calendar, VEEV.US reports fiscal 2027 third-quarter results after the close on Thursday, Dec 3. Current consensus expectations are EPS of $1.6572 and revenue of $935 million, with revenue seen up about 17.99% year on year. Before then, the first half of the coming week brings a run of macro data: the New York Fed manufacturing index on Monday (Nov 16), followed on Tuesday (Nov 17) by US retail sales, retail sales ex-autos, import price index, industrial production, and the NAHB housing market index. A directional surprise in macro data could feed into sector rotation and weigh on VEEV.US’s relative performance.

## In Short

Two forces collided this week. On the company side, the UCB Vault CRM win and the shared-data-platform story dominated, while 23 of 30 covering brokers rate the stock buy or overweight and the consensus target sits above spot. On the market side, the share price made a lower high and lagged the S&P 500 by about 3.23 percentage points, while the most recent session’s capital flow showed large-lot money leaning net seller. Valuation is not cheap at roughly 48.11x trailing P/E and 6.57x P/B. The key question is whether the UCB order momentum shows up in the December results, and whether macro-driven rotation keeps pressuring the stock’s relative performance.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [VEEV.US](https://longbridge.com/en/quote/VEEV.US.md)

## Related News & Research

- [How Investors May Respond To Veeva Systems (VEEV) UCB Adopts Vault CRM](https://longbridge.com/en/news/304766467.md)
- [Can Veeva Systems (VEEV) Justify Its Price On Future Cash Flow?](https://longbridge.com/en/news/304629336.md)
- [Anthropic Stock—The Bull, Base And Bear Case Into Nasdaq-100 Entry](https://longbridge.com/en/news/306338240.md)
- [SanDisk Stock Price Forecast: TrendForce Sees 1Q27 NAND Contract Prices Flat to Down 5%, Shares Face About 40% Downside](https://longbridge.com/en/news/306297576.md)
- [Anthropic's IPO bank closed position meant to stabilize stock, removing source of support](https://longbridge.com/en/news/306308669.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**